Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-16

FDA Approved: THEOPHYLLINE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approves the original generic application for theophylline from PAI Holdings/PAI Pharma, authorizing the sale of a generic theophylline product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

ORIG AP for THEOPHYLLINE (THEOPHYLLINE)